Predictors of mortality and treatment success of multi-drug resistant and Rifampicin resistant tuberculosis in Zimbabwe: a retrospective cohort analysis of patients initiated on treatment during 2010 to 2015

INTRODUCTION: Zimbabwe is one of the 30 countries globally with a high burden of multidrug-resistant TB or rifampicin-resistant TB. The World Health Organization recommended that patients diagnosed with multidrug-resistant TB be treated with 20-24 month standardized second-line drugs since 2010. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Matambo, Ronnie, Nyandoro, George, Sandy, Charles, Nkomo, Tendai, Mutero-Munyati, Shungu, Mharakurwa, Sungano, Chikaka, Elliot, Ngwenya, Mkhokheli, Ndongwe, Gilchriste, Pepukai, Vongai Mildred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418161/
https://www.ncbi.nlm.nih.gov/pubmed/34527144
http://dx.doi.org/10.11604/pamj.2021.39.128.27726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418161/
https://www.ncbi.nlm.nih.gov/pubmed/34527144
http://dx.doi.org/10.11604/pamj.2021.39.128.27726

Ejemplares similares